{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Assessment-only+control&page=2", "query": { "intervention": "Assessment-only control", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Assessment-only+control&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-21T01:34:22.528Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04935294", "title": "Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Renal Dysfunction" ], "interventions": [ { "name": "Danicopan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2018-01-24", "completion_date": "2018-05-29", "has_results": false, "last_update_posted_date": "2021-06-23", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 4, "location_summary": "Miami, Florida • Orlando, Florida • Minneapolis, Minnesota + 1 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04935294" }, { "nct_id": "NCT03051256", "title": "Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depressive Disorder, Major", "Depressive Disorder, Treatment-Resistant" ], "interventions": [ { "name": "REL-1017", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Relmada Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 62, "start_date": "2018-05-11", "completion_date": "2019-09-30", "has_results": true, "last_update_posted_date": "2023-11-01", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • Garden Grove, California • San Diego, California + 7 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03051256" }, { "nct_id": "NCT01517945", "title": "Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Rare Cancer" ], "interventions": [ { "name": "AIM materials and assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 252, "start_date": "2012-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01517945" }, { "nct_id": "NCT02542605", "title": "To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Erenumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PACAP-38 Challenge Agent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 35, "start_date": "2015-11-11", "completion_date": "2017-11-08", "has_results": true, "last_update_posted_date": "2019-06-03", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02542605" }, { "nct_id": "NCT04450342", "title": "REGENETEN™ Bioinductive Implant System in Full-thickness Tears", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rotator Cuff Injuries" ], "interventions": [ { "name": "Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation", "type": "DEVICE" }, { "name": "Arthroscopic rotator cuff repair", "type": "PROCEDURE" }, { "name": "Arthroscopic rotator cuff repair for revision surgery", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Smith & Nephew, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 119, "start_date": "2020-12-07", "completion_date": "2023-10-31", "has_results": true, "last_update_posted_date": "2025-05-23", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 8, "location_summary": "Rome, Georgia • Chicago, Illinois • Baltimore, Maryland + 5 more", "locations": [ { "city": "Rome", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "DeWitt", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04450342" }, { "nct_id": "NCT02257151", "title": "Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult" ], "interventions": [ { "name": "BMS-986142", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 118, "start_date": "2014-09", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-09-24", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02257151" }, { "nct_id": "NCT02098473", "title": "Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "RPC4046", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2014-08-31", "completion_date": "2017-01-30", "has_results": false, "last_update_posted_date": "2017-05-09", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 27, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Oceanside, California + 24 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02098473" }, { "nct_id": "NCT02228395", "title": "Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PF-04958242", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2014-09-22", "completion_date": "2014-11-13", "has_results": true, "last_update_posted_date": "2020-01-07", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02228395" }, { "nct_id": "NCT03108599", "title": "Tech4Rest Trial With Team Truck Drivers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sleep", "Sleep Disturbance", "Sleep Disorder, Shift Work", "Health Knowledge, Attitudes, Practice", "Health Behavior", "Fatigue", "Vibration; Exposure" ], "interventions": [ { "name": "Enhanced Cab", "type": "OTHER" }, { "name": "Fit4Sleep", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 49, "start_date": "2017-05-01", "completion_date": "2021-08-31", "has_results": false, "last_update_posted_date": "2024-07-25", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03108599" }, { "nct_id": "NCT01674036", "title": "Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "Genz-682452", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 63, "start_date": "2012-08", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2014-03-19", "last_synced_at": "2026-09-21T01:34:22.528Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01674036" } ] }